Atlas Trials

A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)

Clinical trial NCT06579755 · RECRUITING

Trial details

NCT number
NCT06579755
Sponsor
Takeda
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Dengue Fever
Start date
2026-01-20
Primary completion
2027-04-14
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.